Jacqueline Shea | Chief Operating Offer And Executive Vice President
Inovio Pharmaceuticals, Inc

Jacqueline Shea, Chief Operating Offer And Executive Vice President, Inovio Pharmaceuticals, Inc

As Chief Operating Officer, Dr. Shea is responsible for Inovio's manufacturing, commercial, business development, and alliance management operations as well as serving as a key member of the executive team and forming and implementing overall corporate strategy. Dr. Shea was previously the CEO at Aeras, the leading not for profit organization dedicated to developing new vaccines against the global number one infectious disease killer, tuberculosis (TB). She has more than 20 years’ experience in the life science industry, working across a range of R&D and senior commercial management roles. She joined Aeras in 2014 as the Chief Operating Officer before being promoted to CEO in 2015. During her tenure Aeras delivered two major clinical breakthroughs in the development of TB vaccines. Prior to Aeras she spent eight years in a variety of senior management roles with Emergent BioSolutions, where from 2008 to 2013 she was General Manager and Vice President of The Oxford-Emergent Tuberculosis Consortium (OETC). Dr. Shea initially trained as a molecular biologist and cell cycle geneticist and has spent much of her career dedicated to developing innovative products to prevent and treat infectious diseases. She holds twenty patents, is an author of numerous scientific publications and has served on multiple advisory boards. She received a BSc in Applied Biology from the University of Bath and a PhD, from the National Institute for Medical Research in the UK.


Pre-congress Workshops, April 6 @ 2:00


Get up to speed on the Coronavirus outbreak, COVID-19: An unprecedented quick and coordinated responseThe WHO: “This outbreak is a test of solidarity -- political, financial and scientific. We need to come together to fight a common enemy that does not respect borders, ensure that we have the resources necessary to bring this outbreak to an end and bring our best science to the forefront to find shared answers to shared problems. Research is an integral part of the outbreak response.”Come together and join us to identify the urgent priorities for research, to mobilize, coordinate and align funding to enable the research needed to tackle this crisis and stop the outbreak, and commit with our experts how you can learn mechanisms for continuing scientific interactions and collaborations, now and beyond the congress.
last published: 05/Mar/20 10:35 GMT

back to speakers

Sign Up for Event Updates